|
Grants & Research
Development of the Quality Donor System™ (QDS) began in 1992 with the
desktop United Blood Services Windows 3.1 application from which has evolved the current QDS
Release 2.11 web technology-based system. Despite this long history, it was not until the late 1990's that the development and regulatory climate in the United States became sufficiently favorable to permit implementation
of QDS in blood banks.
Talisman Limited has received two Small Business Innovation
Research (SBIR) grants from the National
Heart Lung & Blood Institute (NHLBI) for the purpose of developing
automated donor processing systems with emphasis on audio-visual
touch screen computer assisted donor self interviewing (AVT-CASI).
The first SBIR grant (HL61111) was awarded in 1998 for development of a proof-of-concept
version of the QDS software aimed at improving consistency of the
interview process and reducing or eliminating non-decision making human errors
such as incompleteness,
transposition, key entry, donor literacy and communication errors. Legibility problems
are also addressed by QDS. Thomas F. Zuck, MD of the Hoxworth
Blood Center was co-investigator on this effort. The initial Phase I grant was followed
by a Phase II grant in 2000, under which QDS was re-developed as a
web-based system, installed at a mid-sized blood center (Mississippi
Valley Regional Blood Center, Louis M. Katz, MD, Co-investigator) and
subjected to scientific evaluation.
The second SBIR grant (HL072635) for "Paperless Quality Donor
System with Decision making" was awarded in 2003, with a Phase II
follow-on. Under this grant, QDS was
further refined, including installing it in three more blood centers
and a hospital blood bank. Additional development has included
improving performance in a networked environment, QDS in Spanish, prototyping of
vital signs and phlebotomy functions, and implementation of the new
(2004) AABB Uniform Donor History Questionnaire (UDHQ) including
rudimentary decision aids. Further studies (2004) on system performance and
user preferences corroborated earlier work (2001-2002) establishing that QDS
significantly reduces FDA-reportable errors, reduces staff time for
interviews, improves donor disclosure of risky and stigmatizing
behavior and is strongly preferred by donors and blood center staff
compared to
face-to-face interviewing used prior to QDS adoption.
IIn 2005, Talisman was awarded a 3-year competing continuation
grant (HL072635) for FDA-regulated SBIR projects, entitled
“Paperless Quality Donor System with Decision Making”, to carry on
its development and commercialization of its systems. All of the
SBIR grants support the company’s mission to improve the safety and
availability of the US blood supply using information technology
(IT).
Additional details about the individual
grants can be found here.
|
|
| |
All images, text, and other content ©2001-2010
Talisman Limited · 421 F Church Street NE · Vienna, Virginia 22180
Document last updated 9 January 2009
|
|